Kidney Function in People With Cystic Fibrosis in the Era of HEMT
NCT06595420
This study is recruiting at 3 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to find out what causes kidney disease in people with CF. The investigators will study biomarkers in the blood and urine that can either predict who is at risk or detect kidney damage early before it becomes permanent. The study will compare these markers in people with CF over time and during the treatment of lung flare-ups. It will also compare the blood and urine samples obtained from people without CF.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Cystic Fibrosis (CF)
- Chronic Kidney Disease(CKD)
- Acute Kidney Injury
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 7 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Virginia
- Last updated on ClinicalTrials.gov
- May 4, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Alabama · 1
- University of Alabama at Birmingham · Birmingham, AL
New Hampshire · 1
- Dartmouth-Hitchcock Geisel School of Medicine at Dartmouth · Lebanon, NH
Virginia · 1
- University of Virginia Children's Hospital · Charlottesville, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.